| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 09/10/2003 | EP0752890B1 Segmented chelating polymers as imaging and therapeutic agents |
| 09/10/2003 | CN1441680A Cyclodextrin containing glycopeptide antibiotic pharmaceutical compositions |
| 09/10/2003 | CN1440816A Improvement for diagnosis and/or therapeutic agnet and its relative improvement |
| 09/09/2003 | US6617459 8-azabicyclo(3.2.1)oct-2-ene and 9-azabicyclo(3.3.1)non-2-ene derivatives; monoamine neurotransmitter and serotonine reuptake inhibitors; radionuclide-labeled derivatives for diagnosis and detection |
| 09/09/2003 | US6616592 Radioactive medical devices for inhibiting a hyperplastic response and method of making radioactive medical devices |
| 09/09/2003 | US6616591 Radioactive compositions and methods of use thereof |
| 09/09/2003 | CA2138026C Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
| 09/04/2003 | WO2003073437A1 Flow cell, method for separating carrier-free radionuclides, and the radiochemical reaction thereof |
| 09/04/2003 | WO2003072558A2 Arylsulfone derivatives |
| 09/04/2003 | WO2003072144A1 Use of 13c labelled substance for measuring lung function |
| 09/04/2003 | WO2003072142A1 Method of encapsulating metal complex within liposomes |
| 09/04/2003 | WO2003072091A1 Therapeutic methods for acute myeloid leukemia |
| 09/04/2003 | WO2003057006A3 Use of antibodies against the muc18 antigen |
| 09/04/2003 | WO2002049501A3 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 09/04/2003 | US20030166990 Radiation delivery catheters and dosimetry methods |
| 09/04/2003 | US20030166989 Method of radiotherapy |
| 09/04/2003 | US20030166838 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives |
| 09/04/2003 | US20030166507 Water soluble paclitaxel derivatives |
| 09/04/2003 | US20030166004 Comprises synthetic or genetically engineered peptide or polypeptide which comprises endothelial cell binding peptides (ECBP) for inhibit angiogenesis and related diseases such as cancer, arthritis and vision defects |
| 09/04/2003 | US20030165896 Inhibitors of human plasmin derived from the kunitz domains |
| 09/04/2003 | US20030165427 Tuftsin metallopeptide analogs and uses thereof |
| 09/04/2003 | US20030165426 Use of novel metalloporphyrins as imageable tumor-targeting agents for radiation therapy |
| 09/04/2003 | CA2503094A1 Therapeutic methods for acute myeloid leukemia |
| 09/04/2003 | CA2480408A1 A method for encapsulating metal complex in liposomes |
| 09/04/2003 | CA2476173A1 Arylsulfone derivatives |
| 09/04/2003 | CA2475596A1 Use of 13c labelled substance for measuring lung function |
| 09/03/2003 | EP1339752A2 Humanised antibodies and uses thereof |
| 09/03/2003 | EP1339351A2 Directional energy emitting implant |
| 09/03/2003 | EP0651646B1 Therapeutic conjugates of toxins and drugs |
| 09/02/2003 | US6613751 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 09/02/2003 | US6613330 Methods and compositions for preventing anti-Gal production in xenograft recipients |
| 09/02/2003 | US6613305 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 09/02/2003 | US6613304 Radiometal complexes of 2-pyrrolylthiones and their use as radiopharmaceuticals for imaging and therapy |
| 09/02/2003 | US6613303 Aqueous solution of a strontium 90 salt is united with a titanium, zirconium, and/or silicon compound being in a dissolved state and solution of ammonium salts of carbonic acid and/or organic acid; solvent expelled; calcined |
| 09/02/2003 | US6612976 Radioactive medical devices and methods of making radioactive medical devices |
| 08/28/2003 | WO2003071271A1 Test agents for evaluating pharmacological effect of drug, and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or produrgs thereof |
| 08/28/2003 | WO2003070889A2 Prostate specific genes and the use thereof in design or therapeutics |
| 08/28/2003 | WO2003070752A2 Mhc-peptide complex binding ligands |
| 08/28/2003 | WO2003059397A3 Labeling targeting agents with gallium-68 and gallium-67 |
| 08/28/2003 | WO2002086093A9 Methods of using a hyaluronan receptor |
| 08/28/2003 | US20030163017 Multi layer radiation delivery balloon |
| 08/28/2003 | US20030162748 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
| 08/28/2003 | US20030161832 Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen |
| 08/28/2003 | CA2476625A1 Mhc-peptide complex binding ligands |
| 08/28/2003 | CA2474993A1 Diagnostic reagent for evalulation of pharmacological effect of medicine, and method and reagent for screening pharmaceutical agents comprising enzyme, enzyme inhibitor or receptor ligand and/or prodrugs thereof for one having high medicative efficacy and/or small side effect |
| 08/27/2003 | EP1337539A2 Linkable sialyl lewis x analogs |
| 08/27/2003 | EP1337532A2 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
| 08/27/2003 | EP1337278A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 08/27/2003 | EP1337277A1 Radio-labelled ferrite particles and methods for the manufacture and use thereof |
| 08/27/2003 | EP1169046B1 Pulmonary delivery of protonated/acidified nucleic acids |
| 08/27/2003 | EP1033972B1 Drug delivery system with two-step targeting |
| 08/27/2003 | EP0760685B1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 08/27/2003 | CN1438899A Ethylenedicysteine (EC)-drug conjugates |
| 08/27/2003 | CN1438245A Infectious causative-agent related egg-yolk antibody preparation and use thereof |
| 08/27/2003 | CN1438228A Tc N dithiocarbamate compoundÒÇüits preparation method and use in nuclear medicine |
| 08/26/2003 | US6610547 Selection of contrast agent drug from a combinatorial library |
| 08/26/2003 | US6610500 Agonistic anti-human TrkA mAb 5C3 which recognizes the NGF docking site. Such antibodies may be used for the treatment, diagnosis or prevention of neurological diseases, neuromas and neoplastic tumors which express TrkA receptors. |
| 08/26/2003 | US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds |
| 08/26/2003 | US6610270 In vivo determination of metabolic function for use in therapy management |
| 08/26/2003 | US6610269 Disease state imaged using a targeted contrast agent of the formula V-L-R, where V is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker, R is a macromolecular or particulate label |
| 08/21/2003 | WO2003068919A2 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation |
| 08/21/2003 | WO2003068270A1 Method of radio-labelling biomolecules |
| 08/21/2003 | WO2003068269A1 Benzothiazole derivatives for in vivo imaging of amyloid plaques |
| 08/21/2003 | WO2003006070A3 Improved chelator conjugates |
| 08/21/2003 | WO2001094641A3 Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas |
| 08/21/2003 | US20030158393 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes |
| 08/21/2003 | US20030157641 Polycistronic expression of antibodies |
| 08/21/2003 | CA2752553A1 Anti-cd20 antibodies and fusion proteins thereof and methods of use |
| 08/21/2003 | CA2475924A1 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation |
| 08/21/2003 | CA2475522A1 Method of radio-labelling biomolecules |
| 08/21/2003 | CA2474411A1 Benzothiazole derivatives for in vivo imaging of amyloid plaques |
| 08/20/2003 | EP1335717A1 Treatment of pcp addiction and pcp addiction-related behavior |
| 08/20/2003 | EP0996469B1 Methods of photoacoustic imaging |
| 08/20/2003 | CN1437611A 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives |
| 08/20/2003 | CN1437486A Stabiliser for radiopharmaceuticals |
| 08/20/2003 | CN1437478A Intrathecal administration of Rituximab for treatment of central nervous system lymphomas |
| 08/20/2003 | CN1118470C Tc-99m labelled Tc-N nucleated isonitrile compound and its preparation and application |
| 08/19/2003 | US6608174 Of given amino acid sequence; radionuclides; use as scintigraphic imaging agents for visualization of tumors and metastasis |
| 08/19/2003 | US6607710 Provide a bisphosphonic acid derivative and said bisphosphonic acid derivative being labeled with a radioactive nuclide, which has properties of rapid accumulation to the bone and rapid urinary excretion. |
| 08/19/2003 | US6607709 Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma |
| 08/14/2003 | WO2003065991A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 08/14/2003 | WO2003065882A2 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
| 08/14/2003 | WO2003065806A1 New immunoeffector compounds |
| 08/14/2003 | WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer |
| 08/14/2003 | WO2003013346A3 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 08/14/2003 | WO2002081430A3 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors |
| 08/14/2003 | WO2002070020A9 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 08/14/2003 | US20030153736 Diagnosis and prognosis and radiotherapy of metastatic bone disease |
| 08/14/2003 | US20030153734 Via chromatography of immobilized tissue extracts through molecular sieves; animal models; amyloid precursor proteins |
| 08/14/2003 | US20030152514 Methods for using anti-MUC18 antibodies |
| 08/14/2003 | US20030152513 Intravascular delivery of therapeutic and imaging agents to stressed and apoptotic cells using annexin V as a targeting vector |
| 08/14/2003 | US20030152512 Imaging thrombus with glycoprotein llb/llla antagonists |
| 08/14/2003 | US20030152511 The radiolabeling moiety is a sequence of four amino acids capable of complexing with a selected radionuclide in an N4 configuration |
| 08/14/2003 | CA2474398A1 New immunoeffector compounds |
| 08/14/2003 | CA2474142A1 Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| 08/13/2003 | EP1334194A2 Imaging, diagnosis and treatment of disease |
| 08/13/2003 | EP1334091A2 Thioflavin derivatives and their use in diagnosis and therapy of alzheimer's disease |
| 08/13/2003 | EP1333866A1 Polymer based radionuclide containing particulate material |
| 08/13/2003 | EP1333865A1 Inorganic low density radionuclide coated particles |
| 08/13/2003 | EP1333864A1 Low density radionuclide-containing particulate material |